Abstract
Purpose
To compare the efficacy and perioperative complications of the AdVanceXP with the original AdVance male sling.
Methods
We retrospectively enrolled 109 patients with an AdVance and 185 patients with an AdVanceXP male sling. The baseline characteristics and complication rates were analyzed retrospectively. Functional outcome and quality of life were evaluated prospectively by standardized, validated questionnaires. The Chi2-test for categorical and Mann–Whitney U test for continuous variables were performed to identify heterogeneity between the groups.
Results
Regarding operation time, there was no significant difference between the slings (p = 0.146). The complication rates were comparable in both groups except for postoperative urinary retention. This occurred significantly more often in patients with the AdVanceXP (p = 0.042). During follow-up, no differences could be identified regarding ICIQ-SF, PGI or I-QoL or number of pad usage.
Conclusions
The AdVance and AdVanceXP are safe and effective treatment options for male stress urinary incontinence. However, the innovations of the AdVanceXP sling did not demonstrate a superiority over the original AdVance sling regarding functional outcome.
Similar content being viewed by others
Abbreviations
- ICIQ-SF:
-
International Consultation on Incontinence Questionnaire-Short Form
- IPSS:
-
International Prostate Symptome Score
- I-QoL:
-
Incontinence-Quality of Life
- PGI-I:
-
Patient Global Impression-Improvement
- SUI:
-
Stress urinary incontinence
- VRS:
-
Verbal Rating Scale
References
Rehder P, Gozzi C (2007) Transobturator sling suspension for male urinary incontinence including post-radical prostatectomy. Eur Urol 52(3):860–867
Rehder P, Staudacher NM, Schachtner J, Berger ME, Schillfahrt F, Hauser V, Mueller R, Skradski V, Horninger W, Glodny B (2016) Hypothesis that urethral bulb (corpus spongiosum) plays an active role in male urinary continence. Adv Urol 2016:6054730
Bauer RM, Mayer M, Soljanik I, Gratzke C, Bastian PJ, Stief CG, Gozzi C (2009) One year results of the AdVance Sling. J Urol 181(4, Supplement):592–593
Cornu J-N, Sèbe P, Ciofu C, Peyrat L, Beley S, Tligui M, Lukacs B, Traxer O, Cussenot O, Haab F (2009) The AdVance transobturator male sling for postprostatectomy incontinence: clinical results of a prospective evaluation after a minimum follow-up of 6 months. Eur Urol 56(6):923–927
Bauer RM, Mayer ME, May F, Gratzke C, Buchner A, Soljanik I, Bastian PJ, Stief CG, Gozzi C (2010) Complications of the AdVance transobturator male sling in the treatment of male stress urinary incontinence. Urology 75(6):1494–1498
Rehder P, Haab F, Cornu JN, Gozzi C, Bauer RM (2012) Treatment of postprostatectomy male urinary incontinence with the transobturator retroluminal repositioning sling suspension: 3-year follow-up. Eur Urol 62(1):140–145
Bauer RM, Grabbert MT, Klehr B, Gebhartl P, Gozzi C, Homberg R, May F, Rehder P, Stief CG, Kretschmer A (2017) 36-month data for the AdVance XP(R) male sling: results of a prospective multicentre study. BJU Int 119(4):626–630
Cornu J-N, Batista Da Costa J, Henry N, Peyrat L, Beley S, Haab F (2014) Comparative study of AdVance and AdVanceXP male slings in a tertiary reference center. Eur Urol 65(2):502–504
Bauer RM, Kretschmer A, Stief CG, Fullhase C (2015) AdVance and AdVance XP slings for the treatment of post-prostatectomy incontinence. World J Urol 33(1):145–150
Wagner TH, Patrick DL, Bavendam TG, Martin ML, Buesching DP (1996) Quality of life of persons with urinary incontinence: development of a new measure. Urology 47(1):67–71 (discussion 71–62)
Yalcin I, Bump RC (2003) Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 189(1):98–101
Seckiner I, Yesilli C, Mungan NA, Aykanat A, Akduman B (2007) Correlations between the ICIQ-SF score and urodynamic findings. Neurourol Urodyn 26(4):492–494
Twiss CO, Fischer MC, Nitti VW (2007) Comparison between reduction in 24-hour pad weight, International Consultation on Incontinence-Short Form (ICIQ-SF) score, International Prostate Symptom Score (IPSS), and Post-Operative Patient Global Impression of Improvement (PGI-I) score in patient evaluation after male perineal sling. Neurourol Urodyn 26(1):8–13
Barry MJ, Fowler FJ, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT (1992) The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148(5):1549–1557 (discussion 1564)
Rehder P, Haab F, Cornu J-N, Gozzi C, Bauer RM (2012) Treatment of postprostatectomy male urinary incontinence with the transobturator retroluminal repositioning sling suspension: 3-year follow-up. Eur Urol 62(1):140–145
Bauer RM, Soljanik I, Fullhase C, Buchner A, May F, Stief CG, Gozzi C (2011) Results of the AdVance transobturator male sling after radical prostatectomy and adjuvant radiotherapy. Urology 77(2):474–479
Bauer RM, Gozzi C, Klehr B, Kretschmer A, Grabbert M, Rehder P, May F, Stief CG, Gebhartl P, Homberg R (2015) AdVanceXP male sling: 2-year results of a multicentre study. World J Urol 34(7):1025–1030
Bauer RM, Soljanik I, Fullhase C, Karl A, Becker A, Stief CG, Gozzi C (2011) Mid-term results for the retroluminar transobturator sling suspension for stress urinary incontinence after prostatectomy. BJU Int 108(1):94–98
Acknowledgements
This study had no funding.
Author information
Authors and Affiliations
Contributions
TH: design of study, protocol development, data collection, data management, data analysis, manuscript writing, manuscript editing. AK: design of study, protocol development, data collection, data management, manuscript editing. FK and DK: data collection, data management, manuscript editing. MK, LL: data management, manuscript editing. AO, RA, TP, AR, RO, AF, WH, RH, JP, FQ, CMN, JS, CW, JNND, and BB: protocol development, data collection and contribution, data management, manuscript editing. RKH: data contribution, data management, manuscript editing. RA: data collection and contribution, data management, manuscript editing. HL: protocol development, manuscript editing. KU: data management, data analysis, manuscript editing. RMB, AH: design of study, protocol development, data management and contribution, manuscript editing.
Corresponding author
Ethics declarations
Informed consent
This was a retrospective cohort study evaluating perioperative data. Validated questionnaires were utilized prospectively. A signed informed consent from the patients participating in prospective collection of the questionnaires was mandatory for this investigation.
Conflict of interest
T. Hüsch, A. Kretschmer, F. Thomsen, D. Kronlachner, M. Kurosch, A. Obaje, A. Rose, R. Olianas, L. Lusuardi, A. Friedl, R. Anding, R. Kirschner-Hermanns, R. Homberg, J. Pfitzenmaier, U. Grein, F. Queissert, J. Schweiger, C. Wotzka, J. Nyarangi-Dix, B. Brehmer, K. Ulm, and A. Haferkamp have nothing to disclose. R. M. Bauer declares consultancy work, lectures, and participation in clinical trials for AMS/Boston Scientific (Minnetonka, MN, USA) and Promedon (Cordoba, Argentina). C. M. Naumann declares lectures, consultancy work, and participation in clinical trials for Coloplast. W. Hübner declares consultancy work, lectures, and participation in clinical trials for Uromedica (Plymouth, MN, USA) and Promedon (Cordoba, Argentina). T. Pottek declares consultancy work, lectures for Boston Scientific/AMS, Promedon, Zephyr, and Teleflex. R. Abdunnur declares consultancy work, lectures, and participation in clinical trials for AMS/Boston Scientific (Minnetonka, MN, USA) and Promedon (Cordoba, Argentina). Hagen Loertzer declares lectures, consultancy work, and participation in clinical trials for Coloplast.
Rights and permissions
About this article
Cite this article
Hüsch, T., Kretschmer, A., Thomsen, F. et al. The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference?. World J Urol 36, 1657–1662 (2018). https://doi.org/10.1007/s00345-018-2316-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-018-2316-5